Category: Orphan Drugs

We would like to create awareness of rare diseases and the necessity of collaborating to improve the quality of life of those […]

Orphan designation for SYD003 for the treatment of pancreatic cancer. Granted by the European Medicines Agency (EMA) on 22 August 2014 and by […]

Our compound SYD0073 has been granted orphan designation (EU/3/14/1239) by the European Medicines Agency (EMA) for the treatment of cystic fibrosis.